PT-014 - RISK STRATIFICATION WITH PRE-TREATMENT METABOLITE RISK SCORE FOR CARFILZOMIB-RELATED CARDIOTOXICITY IN MULTIPLE MYELOMA PATIENTS.

T. Nguyen¹, M. Tantawy¹, Y. Zhou¹, S. Rubinstein², T. Garrett¹, R. Baz³, M. Fradley⁴, Q. Lu¹, D. Lenihan⁵, R. Cornell⁶, Y. Gong¹; ¹University of Florida, Gainesville, FL, USA, ²University of North Carolina at Chapel Hill, Chapel Hill, NC, USA, ³H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA, ⁴University of Pennsylvania, Philadelphia, PA, USA, ⁵Washington University in St Louis, St Louis, MO, USA, ⁶AbbVie Inc., Chicago, IL, USA.